# Hannah A. Blair

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/hannah-a-blair/

## Facts

| Field | Value |
| --- | --- |
| Citations | 4,980 |
| Field | Psoriasis: Treatment and Pathogenesis |
| h-index | 41 |
| i10-index | 96 |
| Last Known Institution | Bayer (New Zealand) |
| OpenAlex ID | https://openalex.org/A5032695294 |
| Works | 243 |

## Researcher papers

- [Sotorasib: First Approval](https://scholariq.org/papers/sotorasib-first-approval/)
- [Pyrotinib: First Global Approval](https://scholariq.org/papers/pyrotinib-first-global-approval/)
- [Abatacept: A Review in Rheumatoid Arthritis](https://scholariq.org/papers/abatacept-a-review-in-rheumatoid-arthritis/)
- [Belimumab: A Review in Systemic Lupus Erythematosus](https://scholariq.org/papers/belimumab-a-review-in-systemic-lupus-erythematosus/)
- [Tofersen: First Approval](https://scholariq.org/papers/tofersen-first-approval/)
- [Duvelisib: First Global Approval](https://scholariq.org/papers/duvelisib-first-global-approval/)
- [Secukinumab: A Review in Ankylosing Spondylitis](https://scholariq.org/papers/secukinumab-a-review-in-ankylosing-spondylitis/)
- [Safinamide: A Review in Parkinson’s Disease](https://scholariq.org/papers/safinamide-a-review-in-parkinson-s-disease/)
- [Fedratinib: First Approval](https://scholariq.org/papers/fedratinib-first-approval/)
- [Dimethyl Fumarate: A Review in Relapsing-Remitting MS](https://scholariq.org/papers/dimethyl-fumarate-a-review-in-relapsing-remitting-ms/)
- [Tolvaptan: A Review in Autosomal Dominant Polycystic Kidney Disease](https://scholariq.org/papers/tolvaptan-a-review-in-autosomal-dominant-polycystic-kidney-disease/)

## Researcher topics

- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)
- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Asthma and respiratory diseases](https://scholariq.org/topics/asthma-and-respiratory-diseases/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Researcher university

- [Bayer (New Zealand)](https://scholariq.org/institutions/bayer-new-zealand/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.